These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 34725566)

  • 1. Ferroptosis: Opportunities and Challenges in Myocardial Ischemia-Reperfusion Injury.
    Zhao WK; Zhou Y; Xu TT; Wu Q
    Oxid Med Cell Longev; 2021; 2021():9929687. PubMed ID: 34725566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting ferroptosis: a novel insight against myocardial infarction and ischemia-reperfusion injuries.
    Han X; Zhang J; Liu J; Wang H; Du F; Zeng X; Guo C
    Apoptosis; 2023 Feb; 28(1-2):108-123. PubMed ID: 36474078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadening horizons: The role of ferroptosis in myocardial ischemia-reperfusion injury.
    Zhao K; Chen X; Bian Y; Zhou Z; Wei X; Zhang J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2269-2286. PubMed ID: 37119287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fucoxanthin alleviated myocardial ischemia and reperfusion injury through inhibition of ferroptosis
    Yan J; Li Z; Liang Y; Yang C; Ou W; Mo H; Tang M; Chen D; Zhong C; Que D; Feng L; Xiao H; Song X; Yang P
    Food Funct; 2023 Nov; 14(22):10052-10068. PubMed ID: 37861458
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of PPAR-α attenuates myocardial ischemia/reperfusion injury by inhibiting ferroptosis and mitochondrial injury via upregulating 14-3-3η.
    Hu T; Yu WP; Wang XQ; Wang ZY; Xu ZQ; Hu FJ; Liu JC; Yu F; Wang LJ
    Sci Rep; 2024 Jul; 14(1):15246. PubMed ID: 38956068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into myocardial ischemia-reperfusion injury from the perspective of ferroptosis.
    Huang X; Wang Y; Cui X; Yan Q; Xue T; Jing X
    Perfusion; 2024 Sep; ():2676591241280371. PubMed ID: 39264884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liproxstatin-1 protects the mouse myocardium against ischemia/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels.
    Feng Y; Madungwe NB; Imam Aliagan AD; Tombo N; Bopassa JC
    Biochem Biophys Res Commun; 2019 Dec; 520(3):606-611. PubMed ID: 31623831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipid oxidation products in ferroptotic myocardial cell death.
    Stamenkovic A; Pierce GN; Ravandi A
    Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H156-H163. PubMed ID: 31050558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation, ferroptosis, and their potential relationships: Implications in myocardial ischemia-reperfusion injury.
    Yang Y; Ma M; Su J; Jia L; Zhang D; Lin X
    Am J Med Sci; 2023 Sep; 366(3):176-184. PubMed ID: 37290744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular mechanisms and potential drug targets of ferroptosis in myocardial ischemia-reperfusion injury.
    Zhang CH; Yan YJ; Luo Q
    Life Sci; 2024 Mar; 340():122439. PubMed ID: 38278348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynasore Blocks Ferroptosis through Combined Modulation of Iron Uptake and Inhibition of Mitochondrial Respiration.
    Clemente LP; Rabenau M; Tang S; Stanka J; Cors E; Stroh J; Culmsee C; von Karstedt S
    Cells; 2020 Oct; 9(10):. PubMed ID: 33050207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection.
    Ravingerová T; Kindernay L; Barteková M; Ferko M; Adameová A; Zohdi V; Bernátová I; Ferenczyová K; Lazou A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between ferroptosis and mitophagy in cardiac ischemia reperfusion injury: a mini-review.
    Liu C; Li Z; Li B; Liu W; Zhang S; Qiu K; Zhu W
    PeerJ; 2023; 11():e14952. PubMed ID: 36935924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of ferroptosis regulating oxidative stress and energy metabolism in myocardial ischemia-reperfusion injury and a novel perspective of natural plant active ingredients for its treatment.
    Zhang T; Deng W; Deng Y; Liu Y; Xiao S; Luo Y; Xiang W; He Q
    Biomed Pharmacother; 2023 Sep; 165():114706. PubMed ID: 37400352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apelin/APJ System: A Novel Therapeutic Target for Myocardial Ischemia/Reperfusion Injury.
    Chen Z; Wu D; Li L; Chen L
    DNA Cell Biol; 2016 Dec; 35(12):766-775. PubMed ID: 27854125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MPV17 Prevents Myocardial Ferroptosis and Ischemic Cardiac Injury through Maintaining SLC25A10-Mediated Mitochondrial Glutathione Import.
    Xu T; Chen G
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP Facilitates NEDD4L-Mediated Ubiquitination and Degradation of ACSL4 to Alleviate Ferroptosis in Myocardial Ischemia-Reperfusion Injury.
    Qiu M; Yan W; Liu M
    Can J Cardiol; 2023 Nov; 39(11):1712-1727. PubMed ID: 37541340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Insight Into the Fate of Cardiomyocytes in Ischemia-Reperfusion Injury: From Iron Metabolism to Ferroptosis.
    Li JY; Liu SQ; Yao RQ; Tian YP; Yao YM
    Front Cell Dev Biol; 2021; 9():799499. PubMed ID: 34926476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis as a novel therapeutic target for cardiovascular disease.
    Wu X; Li Y; Zhang S; Zhou X
    Theranostics; 2021; 11(7):3052-3059. PubMed ID: 33537073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria "THE" target of myocardial conditioning.
    Boengler K; Lochnit G; Schulz R
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1215-H1231. PubMed ID: 30004243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.